Ion News and Research

RSS

Researchers develop new molecular tools to investigate Alzheimer's disease

One of the many mysteries of Alzheimer's disease is how protein-like snippets called amyloid-beta peptides, which clump together to form plaques in the brain, may cause cell death, leading to the disease's devastating symptoms of memory loss and other mental difficulties.

5 Nov 2009

Third quarter 2009 financial results announced by Synta Pharmaceuticals

Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today reported financial results for the quarter ended September 30, 2009.

4 Nov 2009

The uninsured, putting off care, facing debt

ProPublica profiles Anne Johnson, a 41-year-old single mother in California "whose family has been uninsured since she lost her job as a secretary in February," and explores how health reform could affect her. Johnson "needs her aortic valve replaced, but without insurance she can't afford the surgery. She is supposed to get checkups every six months, but that is also too expensive - so she has put them off."

4 Nov 2009

First Edition: November 3, 2009

Today's headlines focus on the the timing, politics, costs and contents of pending health overhaul bills, as well as a soon-to-be released GOP alternative.

3 Nov 2009

Caliper Life Sciences to use SRU Biosystems’ label-free BIND technology for new functional assays

SRU Biosystems today announced that Caliper Life Sciences will use SRU Biosystems’ label-free BIND® technology to offer new functional assays as part of its Discovery Alliances and Services.

3 Nov 2009

Study of combination therapy versus monotherapy for pulmonary arterial hypertension

Gilead Sciences, Inc., in collaboration with GlaxoSmithKline (GSK), today announced plans for an international, event-driven (morbidity and mortality) clinical trial to study combination therapy versus monotherapy in a first-line treatment setting for pulmonary arterial hypertension (PAH).

2 Nov 2009

Heidelberg Ion Radiation Therapy Center established; European patients can benefit from new radiation therapy

A new, innovative form of radiation based on verified scientific facts will be available to patients all over Europe within the next few decades. The official kick-off meeting of the Community project ULICE (Union of LIght Ions Centres in Europe), which the European Union is supporting with nearly 10 million euros, was held in fall 2009 in the Department of Radiooncology and Radiation Therapy of the Heidelberg University Hospital.

30 Oct 2009

A look at the public insurance options -- What exists and who would have access under proposed reforms

One news outlet studies the practical meaning of public insurance option by examining some of the approaches that are already in existence. Meanwhile, another examines the number of people who would have access to the public plan. And a former insurance executive takes issue with the industry's current stance.

29 Oct 2009

Aquatrove Biosciences announces positive results from Conceive Plus study

Aquatrove Biosciences, Inc. presented positive results from a study demonstrating that the technology used in Conceive Plus™ may assist trying to conceive couples. These data were recently presented at the 65th Annual Meeting of the American Society for Reproductive Medicine (ASRM).

27 Oct 2009

International experts discuss ion radiation therapy

The largest congress worldwide on the topic of particle or ion therapy - radiation with heavy ions and protons - has taken place in the fall of 2009 in Heidelberg. Well over 600 international participants, especially from Japan and the USA, convened in the Heidelberg Town Hall for the annual meeting of the "Particle Therapy Cooperative Group" (PTCOG), including leading experts from the fields of radiation therapy, medical physics and oncology.

27 Oct 2009

Protein crucial for insulin regulation may play a role in diabetes

A cellular protein from a family involved in several human diseases is crucial for the proper production and release of insulin, new research has found, suggesting that the protein might play a role in diabetes.

27 Oct 2009

Vision loss after non-ocular surgery is rare but potentially devastating

Vision loss after non-ocular surgery is a rare but potentially devastating surgical complication that is usually the result of cortical blindness, ischemic optic neuropathy or retinal vascular occlusion. Due to its rare and unexpected occurrence, the origin of perioperative vision loss (POVL) is poorly understood.

26 Oct 2009

Optical system for simultaneous imaging electrical and metabolic quantities in the heart

Cardiac rhythm disorders can result from disturbances in cardiac metabolism. These metabolic changes are tightly linked with specific cardiac electrophysiology (CEP) abnormalities, such as depressed excitability, impaired intra- and extracellular conductivities, wave propagation block, and alteration of conduction velocity, action potential amplitude, and duration.

24 Oct 2009

Thermo Fisher Scientific's revenues decrease by 2% in third quarter 2009

Thermo Fisher Scientific Inc., the world leader in serving science, reported that revenues decreased 2% to $2.53 billion in the third quarter of 2009, compared with $2.59 billion in the 2008 quarter. These results reflect the impact of foreign currency translation, which lowered revenues by 2%, and acquisitions, which increased revenues by 2%. GAAP diluted earnings per share (EPS) were $.53 in 2009, versus $.50 in the year-ago period. GAAP operating income for the 2009 quarter was $275 million, compared with $286 million in 2008, and GAAP operating margin was 10.9%, compared with 11.1% a year ago.

From Thermo Fisher Scientific Inc. 22 Oct 2009

Fluorescent molecule to detect cyanide contamination in drinking water

A small molecule designed to detect cyanide in water samples works quickly, is easy to use, and glows under ultraviolet or "black" light.

22 Oct 2009

Health reform triggers analysis of the lobbying 'revolving door,' spending reports

A joint ProPublica/CBS News investigation found that at least two dozen current lobbyists used to be federal officials who helped design the last major change to American health care.

22 Oct 2009

House Committee votes to strip health insurance industry of federal antitrust exemption

The House Judiciary Committee Wednesday "voted to strip the health insurance industry of its exemption from federal antitrust laws as senators announced plans to take the same step," The Associated Press reports. The committee voted "20 to 9 to repeal a 1940s law that exempted the health insurance industry from federal controls over certain antitrust violations including price-fixing."

22 Oct 2009

First Edition: October 21, 2009

As Senate Democrats wrestle with a doctor payment bill separate from sweeping health care reform proposals, the public plan, public opinion and health care costs continue to be a Capitol Hill focus.

21 Oct 2009

Controlled formation of patchy particles may serve as drug-delivery vehicles to combat disease

Physicists, chemists and engineers at the University of Pennsylvania have demonstrated a novel method for the controlled formation of patchy particles, using charged, self-assembling molecules that may one day serve as drug-delivery vehicles to combat disease and perhaps be used in small batteries that store and release charge.

21 Oct 2009

Researchers develop new technique to study the mechanisms behind diseases in more detail

Researchers have previously been able to analyse which sugar structures are to be found on certain proteins, but not exactly where on the protein they are positioned. This is now possible thanks to a new technique developed at the Sahlgrenska Academy at the University of Gothenburg, Sweden.

20 Oct 2009

Ion News and Research

Researchers develop new molecular tools to investigate Alzheimer's disease

Third quarter 2009 financial results announced by Synta Pharmaceuticals

The uninsured, putting off care, facing debt

First Edition: November 3, 2009

Caliper Life Sciences to use SRU Biosystems’ label-free BIND technology for new functional assays

Study of combination therapy versus monotherapy for pulmonary arterial hypertension

Heidelberg Ion Radiation Therapy Center established; European patients can benefit from new radiation therapy

A look at the public insurance options -- What exists and who would have access under proposed reforms

Aquatrove Biosciences announces positive results from Conceive Plus study

International experts discuss ion radiation therapy

Protein crucial for insulin regulation may play a role in diabetes

Vision loss after non-ocular surgery is rare but potentially devastating

Optical system for simultaneous imaging electrical and metabolic quantities in the heart

Thermo Fisher Scientific's revenues decrease by 2% in third quarter 2009

Fluorescent molecule to detect cyanide contamination in drinking water

Health reform triggers analysis of the lobbying 'revolving door,' spending reports

House Committee votes to strip health insurance industry of federal antitrust exemption

First Edition: October 21, 2009

Controlled formation of patchy particles may serve as drug-delivery vehicles to combat disease

Researchers develop new technique to study the mechanisms behind diseases in more detail

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News